| Aktie | Ticker | Breite | GCS | 2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 603.308.468 $ | +189.201.133 $ | +37,1 % | 27 | 571.789.551 $ | +164.395.590 $ | +40,1 % | 27 | 455.055.852 $ | +126.532.868 $ | +24,0 % | 30 | 380.922.704 $ | +18.653.057 $ | +3,0 % | 23 | ||||
| SPDR SERIES TRUST | → 0 | 93.242.900 $ | +93.242.900 $ | 1 | |||||||||||||||
| ARGENX SE | ARGX | → 0 | 70.897.400 $ | +15.153.036 $ | +27,2 % | 1 | 55.744.364 $ | +2.991.570 $ | +5,7 % | 1 | 52.752.794 $ | -4.356.477 $ | -7,6 % | 1 | 57.109.271 $ | +14.428.306 $ | +33,8 % | 1 | |
| ICON PLC | ICLR | → 0 | Neutral | 53.527.521 $ | +13.855.911 $ | +34,9 % | 1 | 39.671.610 $ | -5.353.130 $ | -11,9 % | 1 | 45.024.740 $ | +13.071.490 $ | +40,9 % | 1 | 31.953.250 $ | +2.457.444 $ | +8,3 % | 1 |
| Guardant Health, Inc. | GH | → 0 | Neutral | 45.111.771 $ | +16.451.115 $ | +57,4 % | 1 | 28.660.656 $ | -357.318 $ | -1,2 % | 1 | 29.017.974 $ | +11.267.406 $ | +63,5 % | 1 | 17.750.568 $ | +6.718.088 $ | +60,9 % | 1 |
| Natera, Inc. | NTRA | → 0 | Neutral | 4.301.668 $ | -20.072.513 $ | -82,4 % | 1 | 24.374.181 $ | -17.609.769 $ | -41,9 % | 1 | 41.983.950 $ | +9.200.156 $ | +28,1 % | 1 | 32.783.794 $ | -7.079.964 $ | -17,8 % | 1 |
| INSMED Inc | INSM | → 0 | Neutral | 40.955.941 $ | +4.283.147 $ | +11,7 % | 1 | 36.672.794 $ | -32.242 $ | -0,1 % | 1 | 36.705.036 $ | -2.408.080 $ | -6,2 % | 1 | 39.113.116 $ | -4.021.188 $ | -9,3 % | 1 |
| BIOMARIN PHARMACEUTICAL INC | BMRN | → 0 | Neutral | 35.743.961 $ | +7.170.811 $ | +25,1 % | 1 | 28.573.150 $ | +6.773.513 $ | +31,1 % | 1 | 21.799.637 $ | +1.933.099 $ | +9,7 % | 1 | 19.866.538 $ | -297.118 $ | -1,5 % | 1 |
| ILLUMINA, INC. | ILMN | → 0 | Neutral | 32.952.828 $ | +9.852.302 $ | +42,6 % | 1 | 23.100.526 $ | -7.218.551 $ | -23,8 % | 1 | 30.319.077 $ | -286.050 $ | -0,9 % | 1 | 30.605.127 $ | -2.154.946 $ | -6,6 % | 1 |
| Scholar Rock Holding Corp | SRRK | → 0 | Neutral | 30.539.960 $ | +6.253.986 $ | +25,8 % | 1 | 24.285.974 $ | +8.282.609 $ | +51,8 % | 1 | 16.003.365 $ | +2.474.073 $ | +18,3 % | 1 | 13.529.292 $ | +3.987.144 $ | +41,8 % | 1 |
| Protagonist Therapeutics, Inc | PTGX | → 0 | Neutral | 30.439.311 $ | +11.538.772 $ | +61,0 % | 1 | 18.900.539 $ | +13.895.957 $ | +277,7 % | 1 | 5.004.582 $ | +5.004.582 $ | 1 | |||||
| Ultragenyx Pharmaceutical Inc. | RARE | → 0 | Neutral | 29.520.800 $ | +10.998.465 $ | +59,4 % | 1 | 18.522.335 $ | -2.443.425 $ | -11,7 % | 1 | 20.965.760 $ | -1.853.776 $ | -8,1 % | 1 | ||||
| COMPASS Pathways plc | CMPS | → 0 | Neutral | 29.155.042 $ | +17.760.881 $ | +155,9 % | 1 | 11.394.161 $ | +910.384 $ | +8,7 % | 1 | 10.483.777 $ | +5.123.648 $ | +95,6 % | 1 | 5.360.129 $ | +5.360.129 $ | 1 | |
| Ascendis Pharma A/S | ASND | → 0 | 28.314.462 $ | +8.495.007 $ | +42,9 % | 1 | 19.819.455 $ | +19.819.455 $ | 1 | ||||||||||
| NEUROCRINE BIOSCIENCES INC | NBIX | → 0 | Stark | 23.089.924 $ | +236.060 $ | +1,0 % | 1 | 22.853.864 $ | -4.446.004 $ | -16,3 % | 1 | ||||||||
| Revolution Medicines, Inc. | RVMD | → 0 | Neutral | 22.538.399 $ | +10.920.525 $ | +94,0 % | 1 | 11.617.874 $ | +2.386.439 $ | +25,9 % | 1 | 9.231.435 $ | +9.231.435 $ | 1 | |||||
| Terns Pharmaceuticals, Inc. | TERN | → 0 | 21.746.842 $ | +10.633.206 $ | +95,7 % | 1 | 11.113.636 $ | +11.113.636 $ | 1 | ||||||||||
| Fortrea Holdings Inc. | FTRE | → 0 | Neutral | 20.554.168 $ | +8.236.953 $ | +66,9 % | 1 | 12.317.215 $ | -8.702.945 $ | -41,4 % | 1 | 21.020.160 $ | +12.694.700 $ | +152,5 % | 1 | 8.325.460 $ | +8.325.460 $ | 1 | |
| BridgeBio Pharma, Inc. | BBIO | → 0 | Neutral | 19.829.722 $ | -4.135 $ | -0,0 % | 1 | 19.833.857 $ | +6.365.815 $ | +47,3 % | 1 | 13.468.042 $ | +2.271.468 $ | +20,3 % | 1 | ||||
| Kymera Therapeutics, Inc. | KYMR | → 0 | Neutral | 19.052.191 $ | +6.907.176 $ | +56,9 % | 1 | 12.145.015 $ | +1.539.512 $ | +14,5 % | 1 | 10.605.503 $ | +10.605.503 $ | 1 | |||||
| BOSTON SCIENTIFIC CORP | BSX | → 0 | Neutral | 15.755.920 $ | -2.639.368 $ | -14,3 % | 1 | 18.395.288 $ | +18.395.288 $ | 1 | |||||||||
| Axsome Therapeutics, Inc. | AXSM | → 0 | Sehr schwach | 15.922.533 $ | +15.922.533 $ | 1 | |||||||||||||
| Alkermes plc. | ALKS | → 0 | Stark | 15.577.138 $ | +7.137.661 $ | +84,6 % | 1 | 8.439.477 $ | +6.150.713 $ | +268,7 % | 1 | 2.288.764 $ | -165.236 $ | -6,7 % | 1 | 2.454.000 $ | +2.454.000 $ | 1 | |
| IONIS PHARMACEUTICALS INC | IONS | → 0 | Schwach | 15.428.010 $ | +15.428.010 $ | 1 | |||||||||||||
| EXACT SCIENCES CORP | EXAS | → 0 | 15.005.490 $ | +181.815 $ | +1,2 % | 1 | 14.823.675 $ | +2.933.600 $ | +24,7 % | 1 | |||||||||
| Tempus AI, Inc. | TEM | → 0 | Sehr schwach | 14.845.663 $ | +3.257.179 $ | +28,1 % | 1 | 11.588.484 $ | +11.588.484 $ | 1 | |||||||||
| PROCEPT BioRobotics Corp | PRCT | → 0 | Neutral | 14.351.113 $ | +4.647.779 $ | +47,9 % | 1 | 9.703.334 $ | -1.304.675 $ | -11,9 % | 1 | 11.008.009 $ | -6.219.517 $ | -36,1 % | 1 | ||||
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Neutral | 12.803.413 $ | +12.803.413 $ | 1 | |||||||||||||
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | → 0 | Neutral | 10.800.816 $ | -4.227.368 $ | -28,1 % | 1 | ||||||||||||
| Akero Therapeutics, Inc. | → 0 | 10.749.472 $ | -1.331.232 $ | -11,0 % | 1 | ||||||||||||||
| AGIOS PHARMACEUTICALS, INC. | AGIO | → 0 | Neutral | 9.883.672 $ | -1.119.734 $ | -10,2 % | 1 | ||||||||||||
| AtaiBeckley Inc. | ATAI | → 0 | Schwach | 9.008.322 $ | +2.957.191 $ | +48,9 % | 1 | 6.051.131 $ | -813.525 $ | -11,9 % | 1 | 6.864.656 $ | +6.864.656 $ | 1 | |||||
| Legend Biotech Corp | LEGN | → 0 | Neutral | 8.884.094 $ | +8.884.094 $ | 1 | |||||||||||||
| Centessa Pharmaceuticals plc | CNTA | → 0 | 8.511.639 $ | +5.933.108 $ | +230,1 % | 1 | 2.578.531 $ | +78.356 $ | +3,1 % | 1 | 2.500.175 $ | +2.500.175 $ | 1 | ||||||
| SOLENO THERAPEUTICS INC | SLNO | → 0 | 6.255.130 $ | +6.255.130 $ | 1 | ||||||||||||||
| uniQure N.V. | QURE | → 0 | Schwach | 4.911.561 $ | +4.911.561 $ | 1 | |||||||||||||
| Praxis Precision Medicines, Inc. | PRAX | → 0 | Sehr schwach | 4.406.658 $ | +4.406.658 $ | 1 | |||||||||||||
| Avalo Therapeutics, Inc. | AVTX | → 0 | Schwach | 4.344.519 $ | +4.344.519 $ | 1 | |||||||||||||
| INTUITIVE SURGICAL INC | ISRG | → 0 | Neutral | 1.745.815 $ | -277.931 $ | -13,7 % | 1 | 2.023.746 $ | -462.574 $ | -18,6 % | 1 | 2.486.320 $ | +522.980 $ | +26,6 % | 1 | 1.963.340 $ | -422.230 $ | -17,7 % | 1 |
| MoonLake Immunotherapeutics | MLTX | → 0 | Schwach | 2.472.568 $ | +2.472.568 $ | 1 | |||||||||||||
| ELI LILLY & Co | LLY | → 0 | Neutral | 2.391.663 $ | +2.391.663 $ | 1 | |||||||||||||
| Disc Medicine, Inc. | IRON | → 0 | Neutral | 2.152.011 $ | +2.152.011 $ | 1 | |||||||||||||
| Immunocore Holdings plc | IMCR | → 0 | Neutral | 1.470.025 $ | +74.080 $ | +5,3 % | 1 | 1.395.945 $ | -211.128 $ | -13,1 % | 1 | 1.607.073 $ | -75.006 $ | -4,5 % | 1 | 1.682.079 $ | +229.185 $ | +15,8 % | 1 |
| Vir Biotechnology, Inc. | VIR | → 0 | Schwach | 1.450.215 $ | +76.960 $ | +5,6 % | 1 | 1.373.255 $ | +161.135 $ | +13,3 % | 1 | ||||||||
| Freenome, Inc. | PCSC | → 0 | 410.024 $ | -3.391 $ | -0,8 % | 1 | 413.415 $ | +413.415 $ | 1 | ||||||||||
| 603.308.468 $ | +189.201.133 $ | +37,1 % | 27 | 571.789.551 $ | +164.395.590 $ | +40,1 % | 27 | 455.055.852 $ | +126.532.868 $ | +24,0 % | 30 | 380.922.704 $ | +18.653.057 $ | +3,0 % | 23 | ||||